Table 2 Antibodies and conditions used for immunohistochemistry
From: Predominance of CIN versus MSI in the development of rectal cancer at young age
Antibody | Clone | Company | Dilution | Buffer |
|---|---|---|---|---|
p53 | DO-7 | DAKO A/S, Glostrup, Denmark | 1:300 | Citrate |
β-catenin | 14 | Transduction laboratories Lexington, KY, USA | 1:5000 | Citrate |
MLH1 | G168-5 | PharMingen, San Diego CA, USA | 1:100 | EDTA |
MSH2 | FE-11 | Oncogene Research Products, Boston, MA, USA | 1:100 | EDTA |